While the IRS for FABP4 was comparable between the normal and overweight/obese group (8.80 versus 9.07), the IRS for ANGTPL4 (6.00 versus 9.80; p = 0.026) and CD36 (2.15 versus 2.60; p = 0.041) were both significantly higher in marginal tumor cells in the overweight/obese group (Table 6). The gene discussed is CD36; the disease is neoplasm.